126 related articles for article (PubMed ID: 7419013)
1. Clinical and biochemical expression of the genetic abnormality in idiopathic hemochromatosis.
Valberg LS; Lloyd DA; Ghent CN; Flanagan PR; Sinclair NR; Stiller CR; Chamberlain MJ
Gastroenterology; 1980 Nov; 79(5 Pt 1):884-92. PubMed ID: 7419013
[No Abstract] [Full Text] [Related]
2. Relationship between genotype, assessed by HLA typing, and phenotypic expression of iron status markers in families of 29 probands with hereditary haemochromatosis.
Milman N; Fenger K; Graudal NA; Nielsen LS
Dan Med Bull; 1994 Jun; 41(3):366-70. PubMed ID: 7924465
[TBL] [Abstract][Full Text] [Related]
3. Histocompatibility antigens as markers of abnormal iron metabolism in idiopathic hemochromatosis.
Lloyd DA; Adams P; Sinclair NR; Stiller CR; Valberg LS
Can Med Assoc J; 1978 Nov; 119(9):1051-6. PubMed ID: 84705
[TBL] [Abstract][Full Text] [Related]
4. Inheritance of hemochromatosis: linkage to HLA.
Cartwright GE; Skolnick M; Amos DB; Edwards CQ; Kravitz K; Johnson A
Trans Assoc Am Physicians; 1978; 91():273-81. PubMed ID: 754395
[No Abstract] [Full Text] [Related]
5. Idiopathic hemochromatosis: a study in a large Puerto Rican family.
Vargas CA; Rubio CE; Rodríguez-Trinidad A; Torres EA
P R Health Sci J; 1993 Dec; 12(4):283-6. PubMed ID: 8140208
[TBL] [Abstract][Full Text] [Related]
6. Unsaturated iron binding capacity and transferrin saturation are equally reliable in detection of HFE hemochromatosis.
Murtagh LJ; Whiley M; Wilson S; Tran H; Bassett ML
Am J Gastroenterol; 2002 Aug; 97(8):2093-9. PubMed ID: 12190182
[TBL] [Abstract][Full Text] [Related]
7. Idiopathic hemochromatosis: a study of biochemical expression in 247 heterozygous members of 63 families: evidence for a single major HLA-linked gene.
Simon M; Fauchet R; Hespel JP; Beaumont C; Brissot P; Hery B; Hita De Nercy Y; Genetet B; Bourel M
Gastroenterology; 1980 Apr; 78(4):703-8. PubMed ID: 7353757
[TBL] [Abstract][Full Text] [Related]
8. The ancestral hemochromatosis haplotype is associated with a severe phenotype expression in Italian patients.
Piperno A; Arosio C; Fargion S; Roetto A; Nicoli C; Girelli D; Sbaiz L; Gasparini P; Boari G; Sampietro M; Camaschella C
Hepatology; 1996 Jul; 24(1):43-6. PubMed ID: 8707280
[TBL] [Abstract][Full Text] [Related]
9. Relative impact of HLA phenotype and CD4-CD8 ratios on the clinical expression of hemochromatosis.
Porto G; Vicente C; Teixeira MA; Martins O; Cabeda JM; Lacerda R; Goncalves C; Fraga J; Macedo G; Silva BM; Alves H; Justiça B; de Sousa M
Hepatology; 1997 Feb; 25(2):397-402. PubMed ID: 9021953
[TBL] [Abstract][Full Text] [Related]
10. Genetic hemochromatosis: distribution analysis of six laboratory measures of iron metabolism.
Borecki IB; Rao DC; Le Mignon L; Yaouanq J; Simon M; Lalouel JM
Am J Med Genet; 1989 Nov; 34(3):435-41. PubMed ID: 2596531
[TBL] [Abstract][Full Text] [Related]
11. [Iron metabolism and its exploration in clinical biology].
Brissot P; Pigeon C; Moirand R; Guyader D; Mendler MH; Sapey T; Deugnier Y; Lescoat G; Loréal O
Ann Biol Clin (Paris); 1998 Jul; 56 Spec No():5-10. PubMed ID: 9827209
[No Abstract] [Full Text] [Related]
12. [Diabetes of idiopathic hemochromatosis is not promoted (except by chance) by diabetic heredity].
Simon M; Alexandre JL; Fauchet R; Genetet N; Scordia C; Jollant M; Hespel JP; Bourel M
Journ Annu Diabetol Hotel Dieu; 1978; ():33-43. PubMed ID: 651105
[No Abstract] [Full Text] [Related]
13. [Idiopathic hemochromatosis. A hereditary defect in the regulation of iron metabolism].
Hauge A
Tidsskr Nor Laegeforen; 1982 Sep; 102(26):1332-4. PubMed ID: 7164080
[No Abstract] [Full Text] [Related]
14. [Hereditary hemochromatosis].
Tokarev IuN; Settarova DA
Klin Med (Mosk); 1988 Mar; 66(3):136-42. PubMed ID: 3292825
[No Abstract] [Full Text] [Related]
15. Clinical and family studies in genetic hemochromatosis: microsatellite and HFE studies in five atypical families.
Adams PC; Campion ML; Gandon G; LeGall JY; David V; Jouanolle AM
Hepatology; 1997 Oct; 26(4):986-90. PubMed ID: 9328324
[TBL] [Abstract][Full Text] [Related]
16. HLA-linked iron overload and myopathy in maintenance hemodialysis patients.
Bregman H; Gelfand MC; Winchester JF; Manz HJ; Knepshield JH
Trans Am Soc Artif Intern Organs; 1980; 26():366-8. PubMed ID: 7245514
[No Abstract] [Full Text] [Related]
17. HLA-linked hemochromatosis and other forms of iron overload.
Bloom PD; Gordeuk VR; MacPhail AP
Dermatol Clin; 1995 Jan; 13(1):57-63. PubMed ID: 7712651
[TBL] [Abstract][Full Text] [Related]
18. [Family screening strategy for genetic hemochromatosis].
Deugnier Y; Fauchet R; Brissot P
Gastroenterol Clin Biol; 1990; 14(8-9):662-8. PubMed ID: 2227239
[No Abstract] [Full Text] [Related]
19. Percent transferrin saturation in segregating hemochromatosis.
Borecki IB; Rao DC; Yaouanq J; Lalouel JM
Am J Med Genet; 1990 Jul; 36(3):301-5. PubMed ID: 2363427
[TBL] [Abstract][Full Text] [Related]
20. Hemochromatosis: current concepts and management.
Crosby WH
Hosp Pract (Off Ed); 1987 Feb; 22(2):173-7, 181-92. PubMed ID: 3100563
[No Abstract] [Full Text] [Related]
[Next] [New Search]